# Syllable Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/syllable

- Industry: Internet
- Headquarters: Sunnyvale, US
- Website: www.syllable.ai
- Total disclosed funding: $72M
- Latest round: Series C (Feb 7, 2022)
- Investors on record: 7

## About

Syllable Corporation develops sophisticated Voice AI agents designed to improve customer service within call centers. Their technology focuses on delivering effective communication solutions across various industries.Founded in 2016 and headquartered in Sunnyvale, California, Syllable Corporation is focused on innovative AI solutions for call centers. The company has completed a total of four deals, with its most recent funding round occurring on February 7, 2022. Syllable raised USD 40.00 mn in Series C funding led by TCV, with participation from Oak HC/FT Partners, Section 32, and Verily Life Sciences LLC. The founders include Adam Spanbauer, Andrew Rogers, Colin Peek, Gui Bastos, Kobus Jooste, and Obroni Davis, with Kobus Jooste currently serving as the CEO.Syllable Corporation specializes in developing advanced Voice AI agents tailored for call center environments, enhancing customer service and brand representation. Their primary product, the Syllable Agentic Platform, provides tools for building, deploying, and managing AI agents utilizing popular Large Language Models (LLMs). Key features include a prompt editor, multilingual support, and audio channel integration, allowing agents to effectively handle both local and toll-free calls. Syllable's solutions cater to various sectors, including healthcare, finance, and retail, serving clients across North America and select regions in Europe and Asia.Syllable Corporation generates revenue primarily through subscription services for its AI platform, enabling clients to efficiently deploy and manage multiple AI agents. Clients enter subscription agreements that grant access to features such as real-time monitoring, deployment management, and analytics for continuous improvement. Subscription plans are tiered based on the number of AI agents and specific functionalities required, enhancing scalability. The company's emphasis on enterprise-grade security and compliance strengthens its value proposition, particularly within regulated industries, fostering long-term client relationships and consistent revenue streams.Following the USD 40.00 mn Series C funding round in April 2022, Syllable Corporation aims to further develop its assistant solution specifically for health system call centers and medical practice offices. The company plans to expand its market presence into additional geographic regions, strategically targeting new areas to enhance customer service capabilities. The recent funding is allocated towards these development initiatives, aligning with Syllable's growth strategy in the competitive AI landscape.

## Funding rounds

- Series C, Feb 7, 2022, $40M — TCV, Oak HC/FT, Section 32, Verily Life Sciences LLC
- Series B, Jun 30, 2021, $28M — Oak HC/FT, Section 32
- Seed, Mar 27, 2017, $4.3M — New Enterprise Associates, Greylock Partners, Khosla Ventures

## Investors

- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Seed
- Greylock Partners (https://capitalatlas.ai/funds/greylock-partners) — Seed
- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Seed
- Oak HC/FT (https://capitalatlas.ai/funds/oak-hc-ft) — Series B, Series C
- Section 32 (https://capitalatlas.ai/funds/section-32) — Series B, Series C
- TCV (https://capitalatlas.ai/funds/tcv) — Series C
- Verily Life Sciences LLC — Series C